Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

Bibliographic Details
Main Authors: Heidi Ko, Rebecca A. Previs, Kyle C. Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Kamal S. Saini
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Oncology and Therapy
Subjects:
HER2-low
Metastatic breast cancer
HER2 testing
HER2-directed antibody–drug conjugate
Online Access:https://doi.org/10.1007/s40487-023-00249-0
Description
ISSN:2366-1070
2366-1089

Similar Items